Analyze in Oracle Skeptic
S7/10Natural
Egyptian firm developing vaccine against the Bundibugyo strain
An Egyptian pharmaceutical company is developing a potential vaccine against the Bundibugyo strain of Ebola, with up to $16.5 million in funding from CEPI to advance the candidate toward human trials as the DRC battles its largest outbreak of the virus.
Source: CGTN WorldOriginal source
Click a tag to subscribe via email/Telegram (manage channels in Account).
⚠️ A model estimate of cascade risk — not a guarantee and not buy/sell. Calibration uses resolved outcomes only; monitor confirmation indicators below.
⏳
Scenario analysis in progress…